• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Ambient Stable X-aptamer Affinity Agents

Ross Durland and colleagues at AM Biotechnologies, LLC in the U.S. propose to develop X-aptamers for detecting and quantifying protein biomarkers for neglected diseases. X-aptamers are modified nucleic acids that tightly bind to specific targets and remain stable at high temperature and humidity. AM Biotech will enhance its process for rapidly identifying X-aptamers that will be integrated into a point-of-care platform for diagnosing many diseases.

More information about Point-of-Care Diagnostics

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.